Registration No. 333- |
Ohio | 95-2680965 | |
(State or other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification Number) | |
One Invacare Way Elyria, Ohio 44035 | ||
(Address of Principal Executive Offices, including Zip Code) |
Anthony C. LaPlaca Senior Vice President, General Counsel and Secretary Invacare Corporation One Invacare Way Elyria, Ohio 44035 (440) 329-6000 (Name, address and telephone number, including area code, of agent for service) | Copy to: Douglas A. Neary, Esq. Calfee, Halter & Griswold LLP The Calfee Building 1405 East Sixth Street Cleveland, Ohio 44114 (216) 622-8200 |
Large accelerated filer | o | Accelerated filer | þ | ||
Non-accelerated filer | o | Smaller reporting company | o |
CALCULATION OF REGISTRATION FEE | ||||
Title of Securities to be Registered | Amount to be Registered (1) | Proposed Maximum Offering Price Per Share (2) | Proposed Maximum Aggregate Offering Price (2) | Amount of Registration Fee |
Prior Plan Shares (3) | 2,325,365 | $13.10 | $30,462,281.50 | $3,530.58 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such additional common shares, without par value (“Common Shares”), of Invacare Corporation (the “Registrant”) as may be issued or become issuable under the terms of the Invacare Corporation 2013 Equity Compensation Plan (the “Plan”), in order to prevent dilution resulting from any stock split, stock dividend or similar transaction. |
(2) | Estimated in accordance with Rule 457(c) and (h) under the Securities Act, solely for the purpose of calculating the registration fee and based upon the average of the high and low sales price of the Common Shares reported on the New York Stock Exchange on December 16, 2016, within five business days prior to filing. |
(3) | The Registration Statement covers 2,325,365 Common Shares (the “Prior Plan Shares”) that are now available for issuance under the Plan because such Common Shares were covered by awards under the Invacare Corporation 2003 Performance Plan, as amended (the “Prior Plan”), that were forfeited or remained unpurchased or undistributed upon termination or expiration of the awards. The Prior Plan Shares were previously registered by the Registrant on a Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the “Commission”), and registration fees were paid for such registration. Concurrently with the filing of this Registration Statement, the Registrant has filed a post-effective amendment to the applicable Registration Statement for the Prior Plan deregistering the Prior Plan Shares that are being carried forward under this Registration Statement. |
1. | The Registrant’s Annual Report on Form 10‑K for the fiscal year ended December 31, 2015; |
2. | The Registrant’s Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2016, June 30, 2016 and September 30, 2016; |
3. | The Registrant’s Current Reports on Form 8-K filed on February 16, 2016, February 23, 2016, March 7, 2016, May 20, 2016, June 8, 2016, July 28, 2016, October 3, 2016, October 6, 2016, November 28, 2016 and November 30, 2016; and |
4. | The description of the Common Shares contained in the Registrant’s Registration Statement on Form 8-A, dated October 22, 1986 (Reg. No. 0-12938) and any amendments and reports filed for the purpose of updating that description; |
INVACARE CORPORATION | ||||
By: | /s/ Matthew E. Monaghan | |||
Matthew E. Monaghan | ||||
Chairman, President and Chief Executive Officer |
Signature | Title | |
/s/ Matthew E. Monaghan | Chairman, President and Chief Executive Officer (Principal Executive Officer) | |
Matthew E. Monaghan | ||
/s/ Robert K. Gudbranson | Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) | |
Robert K. Gudbranson | ||
/s/ Susan H. Alexander | Director | |
Susan H. Alexander | ||
/s/ Michael F. Delaney | Director | |
Michael F. Delaney | ||
/s/ Marc M. Gibeley | Director | |
Marc M. Gibeley | ||
/s/ C. Martin Harris, M.D. | Director | |
C. Martin Harris, M.D. | ||
/s/ Dale C. LaPorte | Director | |
Dale C. LaPorte | ||
/s/ Michael J. Merriman | Director | |
Michael J. Merriman | ||
/s/ Clifford D. Nastas | Director | |
Clifford D. Nastas | ||
/s/ Baiju R. Shah | Director | |
Baiju R. Shah | ||
Exhibit Number | Exhibit Description |
4.1 | Second Amended and Restated Articles of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3(a) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008). |
4.2 | Second Amended and Restated Code of Regulations of the Company, as last amended on February 13, 2014 (incorporated herein by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed on February 14, 2014). |
4.3 | Specimen Share Certificate for Common Shares (incorporated herein by reference to Exhibit 4(a) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005). |
4.4 | Invacare Corporation 2013 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on May 21, 2013). |
4.5 | Amendment No. 1 to the Invacare Corporation 2013 Equity Compensation Plan (incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on May 15, 2015). |
5.1 | Opinion of Calfee, Halter & Griswold LLP (filed herewith). |
23.1 | Consent of Ernst & Young LLP (filed herewith). |
23.2 | Consent of Calfee, Halter & Griswold LLP (included in Exhibit 5.1 of this Registration Statement). |
24.1 | Power of attorney (included on the signature pages of this Registration Statement). |